Satoshi Anai

4.0k total citations
164 papers, 2.8k citations indexed

About

Satoshi Anai is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Satoshi Anai has authored 164 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Pulmonary and Respiratory Medicine, 54 papers in Surgery and 38 papers in Molecular Biology. Recurrent topics in Satoshi Anai's work include Prostate Cancer Treatment and Research (51 papers), Prostate Cancer Diagnosis and Treatment (47 papers) and Bladder and Urothelial Cancer Treatments (43 papers). Satoshi Anai is often cited by papers focused on Prostate Cancer Treatment and Research (51 papers), Prostate Cancer Diagnosis and Treatment (47 papers) and Bladder and Urothelial Cancer Treatments (43 papers). Satoshi Anai collaborates with scholars based in Japan, United States and United Kingdom. Satoshi Anai's co-authors include Kiyohide Fujimoto, Nobumichi Tanaka, Makito Miyake, Noboru Konishi, Keiji Shimada, Yasushi Nakai, Charles J. Rosser, Yoshihiko Hirao, Shunta Hori and Tomomi Fujii and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Clinical Cancer Research.

In The Last Decade

Satoshi Anai

162 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Satoshi Anai Japan	31	959	924	783	741	425	164	2.8k
Makito Miyake Japan	34	1.1k 1.2×	1.1k 1.2×	1.5k 1.9×	987 1.3×	536 1.3×	305	3.9k
Kalyan Saginala United States	12	1.0k 1.1×	1.0k 1.1×	638 0.8×	880 1.2×	424 1.0×	13	2.9k
Sarfraz Ahmad United States	34	800 0.8×	409 0.4×	1.2k 1.5×	712 1.0×	322 0.8×	223	4.0k
Miao‐Fen Chen Taiwan	30	580 0.6×	503 0.5×	770 1.0×	844 1.1×	326 0.8×	88	2.4k
Toshiyuki Kamoto Japan	37	1.4k 1.5×	1.6k 1.7×	788 1.0×	840 1.1×	602 1.4×	262	3.9k
Linda Sugar Canada	37	1.3k 1.3×	1.7k 1.8×	720 0.9×	418 0.6×	856 2.0×	93	3.8k
Kirk J. Wojno United States	36	1.0k 1.1×	1.8k 2.0×	510 0.7×	583 0.8×	431 1.0×	87	3.4k
Piyush K. Agarwal United States	33	716 0.7×	1.2k 1.3×	1.3k 1.6×	461 0.6×	277 0.7×	155	3.0k
Yasutomo Nakai Japan	23	972 1.0×	973 1.1×	539 0.7×	879 1.2×	617 1.5×	79	2.8k
Sandeep Mathur India	27	735 0.8×	552 0.6×	651 0.8×	926 1.2×	519 1.2×	270	3.0k

Countries citing papers authored by Satoshi Anai

Since Specialization

Citations

This map shows the geographic impact of Satoshi Anai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoshi Anai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoshi Anai more than expected).

Fields of papers citing papers by Satoshi Anai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoshi Anai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoshi Anai. The network helps show where Satoshi Anai may publish in the future.

Co-authorship network of co-authors of Satoshi Anai

This figure shows the co-authorship network connecting the top 25 collaborators of Satoshi Anai. A scholar is included among the top collaborators of Satoshi Anai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoshi Anai. Satoshi Anai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kondoh, Chihiro, Woo Kyun Bae, Satoshi Tamada, et al.. (2025). First-line pembrolizumab-axitinib versus sunitinib in metastatic RCC: subgroup analysis of patients enrolled in the phase 3 KEYNOTE-426 in Eastern Asia. Japanese Journal of Clinical Oncology. 55(4). 406–413. 2 indexed citations

Tanaka, Nobumichi, et al.. (2024). Oral 5-aminolevulinic Acid for Patients With Localized Prostate Cancer Undergoing Low-dose-rate Brachytherapy: AMBER Trial. In Vivo. 38(6). 3091–3105. 2 indexed citations

Kadono, Yoshifumi, Hiroyuki Konaka, Takahiro Nohara, et al.. (2023). Efficacy and Safety of First-Line Cytokines Versus Sunitinib and Second-Line Axitinib for Patients with Metastatic Renal Cell Carcinoma (ESCAPE Study): A Phase III, Randomized, Sequential Open-Label Study. Cancers. 15(10). 2745–2745. 1 indexed citations

Miyake, Makito, Takashi Yoshida, Nobutaka Nishimura, et al.. (2022). A prospective, single-arm trial of fluorescent ureteroscopy-assisted thulium-holmium:YAG dual laser ablation for upper urinary tract cancer: Study protocol of the FLUAM trial. Contemporary Clinical Trials Communications. 26. 100902–100902. 6 indexed citations

Anai, Satoshi, Yuri Nakayama, Keita Masuda, et al.. (2022). Diffuse alveolar hemorrhage and acute eosinophilic pneumonia: A rare form of amiodarone pulmonary toxicity diagnosed by bronchoalveolar lavage. Journal of Cardiology Cases. 27(3). 93–96. 2 indexed citations

Miyake, Makito, Nobutaka Nishimura, Takashi Inoue, et al.. (2021). Fluorescent cystoscopy-assisted en bloc transurethral resection versus conventional transurethral resection in patients with non-muscle invasive bladder cancer: study protocol of a prospective, open-label, randomized control trial (the FLEBER study). Trials. 22(1). 136–136. 5 indexed citations

Nishimura, Nobutaka, Shunta Hori, Makito Miyake, et al.. (2020). Living‐donor kidney transplantation for a patient with hypoparathyroidism, deafness, and renal dysplasia syndrome. SHILAP Revista de lepidopterología. 3(6). 244–247. 4 indexed citations

Miyake, Makito, Nobutaka Nishimura, Tomomi Fujii, et al.. (2020). Photodynamic Diagnosis-Assisted En Bloc Transurethral Resection of Bladder Tumor for Nonmuscle Invasive Bladder Cancer: Short-Term Oncologic and Functional Outcomes. Journal of Endourology. 35(3). 319–327. 12 indexed citations

Tanaka, Nobumichi, Isao Asakawa, Yasushi Nakai, et al.. (2020). Coverage of the external prostatic region by the hybrid method compared with the conventional method of prostate low‐dose‐rate brachytherapy: A randomized controlled study. International Journal of Urology. 27(11). 1013–1017. 2 indexed citations

10.

Hori, Shunta, Katsuya Aoki, Yosuke Morizawa, et al.. (2020). Trends in treatment outcomes of hydrocele in Japanese children: A single‐institute experience. International Journal of Urology. 27(11). 946–950. 1 indexed citations

11.

Kadono, Yoshifumi, Hiroyuki Konaka, Kouji Izumi, et al.. (2019). Efficacy and safety of cytokines versus first-line sunitinib and second-line axitinib for patients with metastatic renal cell carcinoma (ESCAPE study): A study protocol for phase III randomized sequential open-label study. Contemporary Clinical Trials Communications. 15. 100403–100403. 3 indexed citations

12.

Nakai, Yasushi, Nobumichi Tanaka, Satoshi Anai, et al.. (2017). Transperineal template-guided saturation biopsy aimed at sampling one core for each milliliter of prostate volume: 103 cases requiring repeat prostate biopsy. BMC Urology. 17(1). 28–28. 13 indexed citations

13.

Tanaka, Nobumichi, Isao Asakawa, Yasushi Nakai, et al.. (2017). Comparison of PSA value at last follow-up of patients who underwent low-dose rate brachytherapy and intensity-modulated radiation therapy for prostate cancer. BMC Cancer. 17(1). 573–573. 19 indexed citations

14.

Morizawa, Yosuke, Makito Miyake, Keiji Shimada, et al.. (2016). Extended resection including adjacent organs and Ki-67 labeling index are prognostic factors in patients with retroperitoneal soft tissue sarcomas. World Journal of Surgical Oncology. 14(1). 43–43. 11 indexed citations

15.

Shimada, Keiji, Tomomi Fujii, Kazutake Tsujikawa, et al.. (2012). ALKBH3 Contributes to Survival and Angiogenesis of Human Urothelial Carcinoma Cells through NADPH Oxidase and Tweak/Fn14/VEGF Signals. Clinical Cancer Research. 18(19). 5247–5255. 69 indexed citations

16.

Fujii, Tomomi, Keiji Shimada, Satoshi Anai, Kiyohide Fujimoto, & Noboru Konishi. (2012). ALKBH2, a novel AlkB homologue, contributes to human bladder cancer progression by regulating MUC1 expression. Cancer Science. 104(3). 321–327. 44 indexed citations

17.

Shimada, Keiji, Mitsutoshi Nakamura, Satoshi Anai, et al.. (2009). A Novel Human AlkB Homologue, ALKBH8, Contributes to Human Bladder Cancer Progression. Cancer Research. 69(7). 3157–3164. 133 indexed citations

18.

Nakamura, Kogenta, Ali Kasraeian, Kenneth A. Iczkowski, et al.. (2009). Utility of serial urinary cytology in the initial evaluation of the patient with microscopic hematuria. BMC Urology. 9(1). 12–12. 23 indexed citations

19.

Pendleton, John, et al.. (2008). Knowledge and Attitudes of Primary Care Physicians Regarding Prostate Cancer Screening. Journal of the National Medical Association. 100(6). 666–673. 15 indexed citations

20.

Rosser, Charles J., et al.. (2007). Outcomes of men who present with elevated serum PSA (greater than 20 ng/mL)to an inner-city hospital. Cancer Epidemiology and Prevention Biomarkers. 16. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact